Advanced Cell Models – Products

InSphero announced its distribution partnership with Chayon. This partnership will bring InSphero’s reliable and scalable 3D in vitro solutions for drug development to South Korean researchers.

iPSC-derived organoid technology drives advances in drug discovery, disease modeling, and personalized medicine. Our cardiac, brain, intestinal, and liver organoids are essential for disease research and therapeutic development.

The life science group Sartorius has published its second edition High-Throughput Screening (HTS) by Cytometry handbook.

AMSBIO has launched CellO-IF – an all-in-one immunofluorescent staining reagent kit designed to accelerate the labelling organoids and spheroids directly in hydrogels or extracellular matrices.

PHC Corporation’s Biomedical Division announced the commercial launch of LiCellMo, a live cell metabolic analyzer that allows researchers to visualize metabolic changes in cell cultures.

Automated robotic instruments are revolutionizing scientific research and bringing more productivity and throughput to routine single-cell isolation workflows. This eBook highlights image-based systems simplify progress in many research applications.

AMSBIO has published an informative online article that reviews the importance of culture techniques for induced pluripotent stem cells (iPSCs), which provide an invaluable resource for drug discovery and therapeutic applications.

Alliance calls on experts to join its new collaborative community, seeking to overcome regulatory and data challenges preventing the replacement and reduction of animal testing.

This whitepaper explores groundbreaking organ-on-a-chip technology and 3D tissue modeling that is closing the translational gap in cancer drug discovery.

Sartorius to leverage NVIDIA solutions used in live-cell imaging platforms in drug discovery and predictive design of manufacturing processes, and more.